You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematologic Agents

Showing 1 - 25 of 7,403
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Acute Myeloid Leukemia Trial in United States (ERAS-007, ERAS-601, Gilteritinib)

Withdrawn
  • Acute Myeloid Leukemia
  • San Francisco, California
  • +3 more
Jun 13, 2022

Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

Active, not recruiting
Has Results
  • Respiratory System Agents
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022

Solid and Hematological Malignancies Trial in Berlin (Capivasertib, Rabeprazole)

Completed
  • Solid and Hematological Malignancies
  • Berlin, Germany
    Research Site
May 6, 2022

Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
May 24, 2022

Solid Tumor, Hematological Malignancy Trial in Beijing (Metoprolol, metoprolol, infliximab, etanercept, tocilizumab and/or other

Recruiting
  • Solid Tumor
  • Hematological Malignancy
  • Metoprolol
  • metoprolol, infliximab, etanercept, tocilizumab and/or other agents
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Apr 8, 2022

Advanced Haematological Malignancies Trial in Worldwide (AZD4573, Acalabrutinib)

Recruiting
  • Advanced Haematological Malignancies
  • Duarte, California
  • +38 more
Jul 22, 2022

Pneumocystis, Steroids, Immunocompromised Patient Trial in Paris (Methylprednisolone, Placebo)

Recruiting
  • Pneumocystis
  • +5 more
  • Paris, France
    Medical ICU
Oct 5, 2020

Oral Anticancer Medications inMultilingual and Multicultural

Unknown status
  • Adults
  • +2 more
  • Measure adherence behaviors
  • Brussels, Belgium
  • +1 more
Nov 2, 2020

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

Evidence Determining Individualized Cancer Therapy for Incurable

Terminated
  • Hematologic Cancer
  • Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
  • La Jolla, California
    UCSD Moore's Cancer Center
Jan 31, 2022

Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

Not yet recruiting
  • Hematologic Neoplasms
  • +5 more
  • umbilical cord derived mesenchymal stem cells
  • Wuhan, Hubei, China
  • +2 more
Jan 3, 2023

B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

Withdrawn
  • B-cell Lymphoma
  • B-cell Leukemia
  • anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

B-Cell Lymphoblastic Leukemia/Lymphoma Trial in Kunming (Anti-CD19 UCAR-NK cells)

Recruiting
  • B-Cell Lymphoblastic Leukemia/Lymphoma
  • Anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 19, 2022

Hematologic Diseases Trial in Haifa (Naturopathic-pharmacological consultation)

Recruiting
  • Hematologic Diseases
  • Naturopathic-pharmacological consultation
  • Haifa, Israel
    Bnai Zion Medical Center
Jul 30, 2023

Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)

Not yet recruiting
  • Hematological Malignancy
  • Neutropenia
  • Morgantown, West Virginia
    Aaron Cumpston
Sep 12, 2022

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
Has Results
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

Solid Tumors Trial in Belgium, France, United States (INCB057643, Gemcitabine, Paclitaxel)

Terminated
Has Results
  • Solid Tumors
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Shenyang, Liaoning, China
    ShengJing Hospital of China Medical University
May 16, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Lymphoma, Non-Hodgkin, Hodgkin Lymphoma Trial in Worldwide (AZD3470)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Miami, Florida
  • +10 more
Nov 13, 2023

Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed

Completed
  • Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy
  • pemetrexed-related hematological toxicity
  • Reims, France
    Chu Reims
Feb 11, 2022

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022